lu-177
Showing 1 - 1 of 1
Neuroendocrine Tumors Trial in Portland (Cabozantinib, Lu-177)
Not yet recruiting
- Neuroendocrine Tumors
- Cabozantinib
- Lu-177
-
Portland, OregonProvidence Portland Cancer Institute - Franz Clinic
Feb 10, 2022